Marksans Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

19 Feb 2018 | 01:11 PM

37.70
-0.25 (-0.66%)

  • Underperforms Index

    -7.14%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 1.75%

  • More Volatile

    3.14%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.11%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

58

58.25

34

34.25

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Marksans Pharma Ltd has decreased by -38.18% since past 3 Months

  • FII shareholding in Marksans Pharma Ltd has decreased by -67.04% since past 1 Year

  • Marksans Pharma Ltd has the highest P/E ratio according to FY 201703 data among stocks in Pharmaceuticals Sector

Loading...